Cannabinoid modulation of subgenual anterior cingulate cortex activation during experience of negative affect

Journal of Neural Transmission

Volumn 119, Issue 6, 2012, Pages 701-707

  Rabinak, Christine A ^a,b   Sripada, Chandra Sekhar ^a   Angstadt, Mike ^a   De Wit, Harriet ^c   Phan, K Luan ^a,b,d  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Amygdala; Cannabinoid; Emotion; FMRI; Subgenual anterior cingulate

Indexed keywords

CANNABINOID; DRONABINOL; PLACEBO;

ADULT; AFFECT; AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; ARTICLE; BEHAVIORAL SCIENCE; CEREBELLUM; ELECTROENCEPHALOGRAM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; MALE; MIDDLE FRONTAL GYRUS; MIDDLE OCCIPITAL GYRUS; NEGATIVE AFFECT; NEUROIMAGING; NEUROMODULATION; NORMAL HUMAN; OCCIPITAL GYRUS; PARIETAL GYRUS; POSTCENTRAL GYRUS; PRIORITY JOURNAL; SUBGENUAL ANTERIOR CINGULATE CORTEX; SUPERIOR FRONTAL GYRUS; SUPERIOR MEDIAL FRONTAL GYRUS; SUPERIOR PARIETAL GYRUS; TASK PERFORMANCE;

ADOLESCENT; ADULT; AFFECT; AROUSAL; DOUBLE-BLIND METHOD; DRONABINOL; EMOTIONS; FEMALE; GYRUS CINGULI; HALLUCINOGENS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; NEUROIMAGING; PHOTIC STIMULATION; REACTION TIME; YOUNG ADULT;

EID: 84863450795     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-011-0747-x     Document Type: Article

References (42)

1. Bhattacharyya S, Morrison PD, Fusar-Poli P, Martin-Santos R, Borgwardt S, Winton-Brown T, Nosarti C, OC CM, Seal M, Allen P, Mehta MA, Stone JM, Tunstall N, Giampietro V, Kapur S, Murray RM, Zuardi AW, Crippa JA, Atakan Z, McGuire PK (2010) Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology 35(3):764-774. doi:10.1038/npp.2009.184
2. Bush G, Luu P, Posner MI (2000) Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci 4(6):215-222 pii:S1364-6613(00)01483- 2
3. Chait LD, Fischman MW, Schuster CR (1985) 'Hangover' effects the morning after marijuana smoking. Drug Alcohol Dep 15(3): 229-238
4. Cornelius JR, Aizenstein HJ, Hariri AR (2010) Amygdala reactivity is inversely related to level of cannabis use in individuals with comorbid cannabis dependence and major depression. Addict Behav 35(6):644-646. doi:10.1016/j.addbeh.2010.02.004
5. Drevets WC (1998) Functional neuroimaging studies of depression: the anatomy of melancholia. Annu Rev Med 49:341-361. doi: 10.1146/annurev.med.49.1. 341
6. Drevets WC, Price JL, Simpson JR Jr, Todd RD, Reich T, Vannier M, Raichle ME (1997) Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386(6627):824-827. doi:10.1038/386824a0
7. Drevets WC, Price JL, Furey ML (2008) Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct 213(1-2):93-118. doi:10.1007/s00429-008-0189-x
8. Dubreucq S, Koehl M, Abrous DN, Marsicano G, Chaouloff F (2010) CB1 receptor deficiency decreases wheel-running activity: consequences on emotional behaviours and hippocampal neurogenesis. Exp Neurol 224(1):106-113. doi:10.1016/j.expneurol.2010.01.017
9. Eggan SM, Lewis DA (2007) Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. Cereb Cortex 17(1):175-191. doi: 10.1093/cercor/bhj136
10. Friston KJ, Frith CD, Frackowiak RS, Turner R (1995) Characterizing dynamic brain responses with fMRI: a multivariate approach. NeuroImage 2(2):166-172 pii:S1053811985710191
11. Fusar-Poli P, Crippa JA, Bhattacharyya S, Borgwardt SJ, Allen P, Martin-Santos R, Seal M, Surguladze SA, O'Carrol C, Atakan Z, Zuardi AW, McGuire PK (2009) Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch Gen Psychiatry 66(1): 95-105. doi:10.1001/archgenpsychiatry.2008.519
12. Fusar-Poli P, Allen P, Bhattacharyya S, Crippa JA, Mechelli A, Borgwardt S, Martin-Santos R, Seal ML, O'Carrol C, Atakan Z, Zuardi AW, McGuire P (2010) Modulation of effective connectivity during emotional processing by Delta 9-tetrahydrocannabinol and cannabidiol. Int J Neuropsychopharmacol 13(4): 421-432. doi:10.1017/S1461145709990617
13. Gaetani S, Dipasquale P, Romano A, Righetti L, Cassano T, Piomelli D, Cuomo V (2009) The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs. Int Rev Neurobiol 85:57-72. doi:10.1016/S0074-7742(09) 85005-8
14. George MS, Ketter TA, Parekh PI, Horwitz B, Herscovitch P, Post RM (1995) Brain activity during transient sadness and happiness in healthy women. Am J Psychiatry 152(3):341-351
15. Gobbi G, Bambico FR, Mangieri R, Bortolato M, Campolongo P, Solinas M, Cassano T, Morgese MG, Debonnel G, Duranti A, Tontini A, Tarzia G, Mor M, Trezza V, Goldberg SR, Cuomo V, Piomelli D (2005) Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci USA 102(51):18620-18625. doi:10.1073/pnas. 0509591102
16. Gruber SA, Rogowska J, Yurgelun-Todd DA (2009) Altered affective response in marijuana smokers: an FMRI study. Drug Alcohol Depend 105(1-2):139-153. doi:10.1016/j.drugalcdep.2009.06.019
17. Hall W, Solowij N (1998) Adverse effects of cannabis. Lancet 352(9140):1611-1616. doi:10.1016/S0140-6736(98)05021-1
18. Harmer CJ, Mackay CE, Reid CB, Cowen PJ, Goodwin GM (2006) Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol Psychiatry 59(9):816-820. doi: 10.1016/j.biopsych.2005.10.015
19. Hayase T (2007) Chronologically overlapping occurrences of nicotine-induced anxiety- and depression-related behavioral symptoms: effects of anxiolytic and cannabinoid drugs. BMC Neurosci 8:76. doi:10.1186/1471-2202-8-76
20. Hill MN, Gorzalka BB (2009) The endocannabinoid system and the treatment of mood and anxiety disorders. CNS Neurol Disord Drug Targ 8(6):451-458 pii:HT-2(Puffenbarger)
21. Hollister LE (1986) Health aspects of cannabis. Pharmacol Rev 38(1):1-20
22. Johanson CE, Uhlenhuth EH (1981) Drug preference and mood in humans: repeated assessment of d-amphetamine. Pharmacol Biochem Behav 14(2):159-163
23. Kirk JM, de Wit H (1999) Responses to oral delta9-tetrahydrocannabinol in frequent and infrequent marijuana users. Pharmacol Biochem Behav 63(1):137-142
24. Kober H, Barrett LF, Joseph J, Bliss-Moreau E, Lindquist K, Wager TD (2008) Functional grouping and cortical-subcortical interactions in emotion: a meta-analysis of neuroimaging studies. NeuroImage 42(2):998-1031. doi:10.1016/j.neuroimage.2008.03.059
25. Lang PJ, Bradley MM, Buthbert BN (2008) International affective picture system (IAPS): Affective ratings of pictures and instruction manual. Technical Report A-8. University of Florida, Gainsville
26. Mailleux P, Parmentier M, Vanderhaeghen JJ (1992) Distribution of cannabinoid receptor messenger RNA in the human brain: an in situ hybridization histochemistry with oligonucleotides. Neurosci Lett 143(1-2):200-204
27. Martin WR, Sloan JW, Sapira JD, Jasinski DR (1971) Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12(2):245-258
28. Mayberg HS (2003) Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull 65:193-207
29. Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA, Silva JA, Tekell JL, Martin CC, Lancaster JL, Fox PT (1999) Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 156(5):675-682
30. Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, Schwalb JM, Kennedy SH (2005) Deep brain stimulation for treatment-resistant depression. Neuron 45(5): 651-660. doi:10.1016/j.neuron.2005.02.014
31. Moldrich G, Wenger T (2000) Localization of the CB1 cannabinoid receptor in the rat brain. An immunohistochemical study. Peptides 21(11):1735-1742 pii:S0196-9781(00)00324-7
32. Paulus MP, Feinstein JS, Castillo G, Simmons AN, Stein MB (2005) Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing. Arch Gen Psychiatry 62(3):282-288. doi:10.1001/archpsyc.62.3.282
33. Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR (2005) 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 8(6):828-834. doi: 10.1038/nn1463
34. Phan KL, Wager T, Taylor SF, Liberzon I (2002) Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI. NeuroImage 16(2):331-348. doi: 10.1006/nimg.2002.1087
35. Phan KL, Angstadt M, Golden J, Onyewuenyi I, Popovska A, de Wit H (2008) Cannabinoid modulation of amygdala reactivity to social signals of threat in humans. J Neurosci 28(10):2313-2319
36. Pizzagalli DA (2010) Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacology 36(1):183-206. doi:10.1038/npp.2010.166
37. Pizzagalli DA (2011) Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacology 36(1):183-206. doi:10.1038/npp.2010.166
38. Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM (1998) Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83(2):393-411 pii:S0306452297004363
39. Wachtel SR, ElSohly MA, Ross SA, Ambre J, de Wit H (2002) Comparison of the subjective effects of Delta (9)-tetrahydrocannabinol and marijuana in humans. Psychopharmacology (Berl) 161(4):331-339
40. Walter B, Blecker C, Kirsch P, Sammer G, Schienle A, Stark R, Vaitl D MARINA (2003) An easy tool for the creation for MAsks for Region of Interest Analyses. In: 9th international conference on functional mapping of the human brain, NeuroImage June 2003 New York, pp 19-22
41. Westlake TM, Howlett AC, Bonner TI, Matsuda LA, Herkenham M (1994) Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains. Neuroscience 63(3):637-652 pii:0306-4522(94)90511-8
42. Zink CF, Stein JL, Kempf L, Hakimi S, Meyer-Lindenberg A (2010) Vasopressin modulates medial prefrontal cortex-amygdala circuitry during emotion processing in humans. J Neurosci 30(20):7017-7022. doi:10.1523/JNEUROSCI.4899- 09.2010